Humanized CD19-specific chimeric antigen-receptor T-cells in 2 adults with newly diagnosed B-cell acute lymphoblastic leukemia

被引:0
|
作者
Jiang Cao
Hai Cheng
Ming Shi
Gang Wang
Wei Chen
Kunming Qi
Huizhong Li
Jianlin Qiao
Jing Zhao
Qingyun Wu
Lingyu Zeng
Guangjun Jing
Junnian Zheng
Kailin Xu
机构
[1] The Affiliated Hospital of Xuzhou Medical University,Department of Hematology
[2] Xuzhou Medical University,Cancer Institute
[3] Jiangsu Bone Marrow Stem Cell Institute,Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute
[4] iCARTAB biomedical co. Ltd,Center of Clinical Oncology
[5] Xuzhou Medical University,undefined
[6] The Affiliated Hospital of Xuzhou Medical University,undefined
来源
Leukemia | 2019年 / 33卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2751 / 2753
页数:2
相关论文
共 50 条
  • [21] Chimeric antigen receptor T-cells for B-cell malignancies
    Lichtman, Eben I.
    Dotti, Gianpietro
    TRANSLATIONAL RESEARCH, 2017, 187 : 59 - 82
  • [22] Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients
    Stock, Sophia
    Uebelhart, Rudolf
    Schubert, Maria-Luisa
    Fan, Fuli
    He, Bailin
    Hoffmann, Jean-Marc
    Wang, Lei
    Wang, Sanmei
    Gong, Wenjie
    Neuber, Brigitte
    Hueckelhoven-Krauss, Angela
    Gern, Ulrike
    Christ, Christiane
    Hexel, Monika
    Schmitt, Anita
    Schmidt, Patrick
    Krauss, Juergen
    Jaeger, Dirk
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Sellner, Leopold
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (05) : 1312 - 1324
  • [23] High cytotoxic efficiency of alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells for treatment of acute lymphoblastic leukemia
    Mueller, Stephan
    Bexte, Tobias
    Heinze, Annekathrin
    Schenk, Franziska
    Schambach, Axel
    Wels, Winfried S.
    Modlich, Ute
    Ullrich, Evelyn
    BONE MARROW TRANSPLANTATION, 2019, 54 : 293 - 294
  • [24] CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia
    Zheng, Nai-Shan
    Zhao, Xiang-Yu
    Wei, Ding
    Miao, Jin-Lin
    Liu, Ze-Kun
    Yong, Yu-Le
    Zhang, Ren-Yu
    Guo, Yi-Xiao
    He, Lin
    Wang, Bin
    Sun, Xiu-Xuan
    Yang, Hai-Jiao
    Zhang, Tian-Jiao
    He, Qian
    Li, Xiao-Min
    Zhang, Hai
    Hou, Rong
    Lin, Peng
    Xu, Ying-Ming
    Huang, Xiao-Jun
    Chen, Zhi-Nan
    Bian, Huijie
    CANCER LETTERS, 2022, 542
  • [25] CD19 Chimeric Antigen Receptor T Cell Therapy for the Treatment of B Cell Lineage Acute Lymphoblastic Leukemia
    Chen, Runzhe
    Song, Xiao-Tong
    Chen, Baoan
    DISCOVERY MEDICINE, 2015, 20 (110) : 185 - 190
  • [26] Tol2 Transposon System Mediates Stable Gene Transfer of CD19-Specific Chimeric Antigen Receptor To Primary Human T-Cells for the Treatment of B-Cell Malignancies
    Tsukahara, Tomonori
    Iwase, Nozomi
    Yamamoto, Chihiro
    Ohmine, Ken
    Uchibori, Ryosuke
    Teruya, Takeshi
    Ido, Hiroyuki
    Urabe, Masashi
    Mizukami, Hiroaki
    Kume, Akihiro
    Nakamura, Masataka
    Brentjens, Renier
    Kawakami, Koichi
    Ozawa, Keiya
    MOLECULAR THERAPY, 2014, 22 : S162 - S163
  • [27] Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor
    Deniger, Drew C.
    Switzer, Kirsten
    Mi, Tiejuan
    Maiti, Sourindra
    Hurton, Lenka
    Singh, Harjeet
    Huls, Helen
    Olivares, Simon
    Lee, Dean A.
    Champlin, Richard E.
    Cooper, Laurence J. N.
    MOLECULAR THERAPY, 2013, 21 (03) : 638 - 647
  • [28] Construction and Testing of Two Distinct Humanized CD19-Specific Chimeric Antigen Receptors (CARs) for the Treatment of B-Cell Malignancies
    Gopalakrishnan, Ramakrishnan
    Matta, Hittu
    Choi, Sunju
    Han, Xu
    Prakash, Rekha
    Narasappa, Nell
    Gong, Songjie
    Chitnis, Saurabh
    Kahn, Michael
    Sernas, Jennifer
    Khan, Prottasha
    Chaudhary, Preet
    BLOOD, 2016, 128 (22)
  • [29] CD19-specific car-t cells for the treatment of cns chloromas in children with relapsed/refractory b-cell acute lymphoblastic leukemia
    Shahid, S.
    Cancio, M.
    Haque, S. S.
    Khakoo, Y.
    McWilliams, E.
    Santomasso, B. D.
    Scaradavou, A.
    Spitzer, B.
    Wolden, S. L.
    Boelens, J. J.
    Curran, K. J.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 137 - 138
  • [30] Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients
    Qi, Yuekun
    Zhao, Mingfeng
    Hu, Yongxian
    Wang, Ying
    Li, Ping
    Cao, Jiang
    Shi, Ming
    Tan, Jiaqi
    Zhang, Meng
    Xiao, Xia
    Xia, Jieyun
    Ma, Sha
    Qiao, Jianlin
    Yan, Zhiling
    Li, Hujun
    Pan, Bin
    Sang, Wei
    Li, Depeng
    Li, Zhenyu
    Zhou, Jianfeng
    Huang, He
    Liang, Aibin
    Zheng, Junnian
    Xu, Kailin
    BLOOD, 2022, 139 (23) : 3376 - 3386